Nisa Investment Advisors
SRPT icon

Nisa Investment Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Nisa Investment Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.5K Buy
3,254
+2,730
+521% +$51.6K ﹤0.01% 1793
2026
Q1 		$11.4K Sell
524
-1,809
-78% -$35K ﹤0.01% 2195
2025
Q4 		$50.2K Sell
2,333
-37,976
-94% -$800K ﹤0.01% 1613
2025
Q3 		$777K Buy
40,309
+40,213
+41,889% +$717K ﹤0.01% 911
2025
Q2 		$1.64K Sell
96
-1,054
-92% -$45K ﹤0.01% 2641
2025
Q1 		$73.4K Sell
1,150
-167
-13% -$17.6K ﹤0.01% 1480
2024
Q4 		$160K Buy
1,317
+247
+23% +$30.3K ﹤0.01% 1352
2024
Q3 		$134K Buy
1,070
+155
+17% +$21.4K ﹤0.01% 1370
2024
Q2 		$145K Sell
915
-30
-3% -$3.85K ﹤0.01% 1388
2024
Q1 		$122K Buy
945
+600
+174% +$73.5K ﹤0.01% 1416
2023
Q4 		$33.3K Hold
345
– – ﹤0.01% 1729
2023
Q3 		$41.8K Sell
345
-8,103
-96% -$916K ﹤0.01% 1775
2023
Q2 		$967K Sell
8,448
-1,647
-16% -$212K 0.01% 886
2023
Q1 		$1.39M Buy
10,095
+9,710
+2,522% +$1.26M 0.01% 763
2022
Q4 		$50K Hold
385
– – ﹤0.01% 1770
2022
Q3 		$43K Sell
385
-155
-29% -$15.6K ﹤0.01% 1800
2022
Q2 		$40K Sell
540
-350
-39% -$25.7K ﹤0.01% 1810
2022
Q1 		$70K Sell
890
-1,341
-60% -$103K ﹤0.01% 1743
2021
Q4 		$160K Sell
2,231
-850
-28% -$72.7K ﹤0.01% 1345
2021
Q3 		$285K Sell
3,081
-966
-24% -$74.4K ﹤0.01% 1291
2021
Q2 		$315K Sell
4,047
-1,400
-26% -$106K ﹤0.01% 1262
2021
Q1 		$406K Sell
5,447
-825
-13% -$76.1K ﹤0.01% 1226
2020
Q4 		$1.07M Buy
6,272
+1,511
+32% +$224K 0.01% 896
2020
Q3 		$669K Sell
4,761
-2,227
-32% -$338K 0.01% 946
2020
Q2 		$1.12M Buy
6,988
+2,718
+64% +$370K 0.01% 759
2020
Q1 		$418K Buy
4,270
+3,050
+250% +$349K ﹤0.01% 975
2019
Q4 		$157K Sell
1,220
-1,425
-54% -$144K ﹤0.01% 1366
2019
Q3 		$199K Buy
2,645
+1,320
+100% +$156K ﹤0.01% 1328
2019
Q2 		$201K Buy
1,325
+125
+10% +$15.2K ﹤0.01% 1310
2019
Q1 		$143K Sell
1,200
-1,916
-61% -$246K ﹤0.01% 1370
2018
Q4 		$340K Buy
3,116
+600
+24% +$75K ﹤0.01% 1112
2018
Q3 		$406K Buy
+2,516
New +$344K ﹤0.01% 1160
2018
Q2 		– Sell
-275
Closed -$20K – 1896
2018
Q1 		$20K Sell
275
-225
-45% -$15K ﹤0.01% 1488
2017
Q4 		$28K Hold
500
– – ﹤0.01% 1494
2017
Q3 		$23K Hold
500
– – ﹤0.01% 1506
2017
Q2 		$17K Buy
500
+180
+56% +$5.86K ﹤0.01% 1532
2017
Q1 		$9K Sell
320
-280
-47% -$8.67K ﹤0.01% 1712
2016
Q4 		$16K Buy
+600
New +$24.1K ﹤0.01% 1703

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nisa Investment Advisors's SRPT Position: Q2 2026 in Review

Nisa Investment Advisors increased its Sarepta Therapeutics (SRPT) stake by 521% in Q2 2026, buying an estimated $51.6K and bringing the position to 3,254 shares worth $58.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Nisa Investment Advisors first reported a position in SRPT in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.39M in Q1 2023. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Nisa Investment Advisors held 3,254 shares of Sarepta Therapeutics worth $58.5K as of Q2 2026.
  • Nisa Investment Advisors bought 2,730 Sarepta Therapeutics shares in Q2 2026, an estimated $51.6K.
  • Sarepta Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1793 holding.
  • Nisa Investment Advisors first reported a position in Sarepta Therapeutics in Q4 2016 and has held it in 38 quarters since.
  • Nisa Investment Advisors's Sarepta Therapeutics position peaked at $1.39M in Q1 2023.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.